Elicio, based in Cambridge Ma, is committed to transforming the lives of patients & their families by re-engineering the body’s immune response to defeat cancer. By combining expertise in materials science & immunology, Elicio is engineering potent Amphiphile immunotherapies including lymph node targeted cell therapy activators, immunomodulators, & vaccines for an array of aggressive cancers. Elicio was founded to expand & a...
Elicio, based in Cambridge Ma, is committed to transforming the lives of patients & their families by re-engineering the body’s immune response to defeat cancer. By combining expertise in materials science & immunology, Elicio is engineering potent Amphiphile immunotherapies including lymph node targeted cell therapy activators, immunomodulators, & vaccines for an array of aggressive cancers. Elicio was founded to expand & apply the ground-breaking Amphiphile technology invented and developed by Darrell Irvine Ph.D. Elicio’s lead Amphiphile vaccine targeting pancreatic cancer & colorectal cancer will begin initial patient studies in 2020.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.